Please login to the form below

Not currently logged in
Email:
Password:

cyclosporine

This page shows the latest cyclosporine news and features for those working in and with pharma, biotech and healthcare.

Court throws out Allergan's patent deal with Native American tribe

Court throws out Allergan's patent deal with Native American tribe

A US judge has sent Allergan into a spin following a ruling on patents protecting its blockbuster dry eye treatment Restasis (cyclosporine ophthalmic emulsion).

Latest news

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    market. Some peptides - such as transplant rejection drug cyclosporine and diuretic hormone desmopressin acetate - are simple enough to be amenable to standard oral formulation technologies and so have been available for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics